Výsledky vyhledávání - "Erven, L. van"

Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy:An updated meta-analysis and effect on Dutch clinical practice by the Task Force of the Dutch Society of Cardiology

Autor: Theuns, D.A., Verstraelen, T.E., Lingen, A.C.J. van der, Delnoy, P.P., Allaart, C.P., Erven, L. van, Maass, A.H., Vernooy, K., Wilde, A.A.M., Boersma, E., Meeder, J.G.

Publikováno v: Theuns, D A, Verstraelen, T E, van der Lingen, A C J, Delnoy, P P, Allaart, C P, van Erven, L, Maass, A H, Vernooy, K, Wilde, A A M, Boersma, E & Meeder, J G 2022, ' Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy : An updated meta-analysis and effect on Dutch clinical practice by the Task Force of the Dutch Society of Cardiology ', Netherlands Heart Journal . https://doi.org/10.1007/s12471-022-01718-3
Netherlands Heart Journal, 31, 89-99. BOHN STAFLEU VAN LOGHUM BV

Background Primary prophylactic implantable cardioverter-defibrillators (ICDs) in patients with non-ischaemic cardiomyopathy (NICMP) remains controversial. This study sought to assess the benefit of ICD therapy with or without cardiac resynchronisati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e519dd46d7110efdc7342024ff84fd82
https://research.vumc.nl/en/publications/6478c589-188d-45b9-b3b3-784fcc8a28a4

Zobrazit plný text záznamu

Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients The Prospective, Randomized, Controlled ICD2 Trial

Autor: Jukema, J.W., Timal, R.J., Rotmans, J.I., Hensen, L.C.R., Buiten, M.S., Bie, M.K. de, Putter, H., Zwinderman, A.H., Erven, L. van, Krol-van Straaten, M.J., Hommes, N., Gabreels, B., Dorp, W. van, Dam, B. van, Herzog, C.A., Schalij, M.J., Rabelink, T.J., ICD2 Trial Investigators

Publikováno v: Circulation, 139(23), 2628-2638

Background: Patients with end-stage renal disease who are undergoing dialysis are reported to be at high risk of sudden cardiac death (SCD), and to date, no therapy has been shown to be effective in reducing this risk. The feasibility and value of pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dfd6ba23f71efd055e94bfc79f17986
http://hdl.handle.net/1887/121366

Zobrazit plný text záznamu

Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing:The SELECT-LV Study

Autor: Reddy, V.Y., Miller, M.A., Neuzil, P., Sogaard, P., Butter, C., Seifert, M., Delnoy, P.P., Erven, L. van, Schalji, M., Boersma, L.V.A., Riahi, S.

Publikováno v: Reddy, V Y, Miller, M A, Neuzil, P, Søgaard, P, Butter, C, Seifert, M, Delnoy, P P, van Erven, L, Schalji, M, Boersma, L V A & Riahi, S 2017, ' Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing : The SELECT-LV Study ', Journal of the American College of Cardiology, vol. 69, no. 17, pp. 2119-2129 . https://doi.org/10.1016/j.jacc.2017.02.059
Journal of the American College of Cardiology, 69(17), 2119-2129

BACKGROUND: A total of 30% to 40% of patients with congestive heart failure eligible for cardiac resynchronization therapy (CRT) either do not respond to conventional CRT or remain untreated due to an inability or impediment to coronary sinus (CS) le

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e9f199357988fdc8e8d219464e61cc89
https://vbn.aau.dk/da/publications/ad049030-15f8-44fa-a071-7481efd13a12

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání